Baxter International | BAX - Srodki Pieniężne I Ekwiwalent

Cena Akcji
17.61
Dzienna Zmiana
0.71 4.20%
Miesięcznie
4.82%
Rocznie
-42.58%
Q2 Prognozy TE
17.77




Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 64.91M 8.52M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Avanos Medical USD 89.8M 19.3M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.4B 538M 2026-03
Fresenius EUR 1.23B 1.16B 2025-06
Globus Medical USD 526.16M 154.39M 2025-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
ICU Medical USD 307.96M 8.23M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
J&J USD 21.69B 1.98B 2026-03
Laboratory Of America USD 532.3M 65.8M 2025-12
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Quest Diagnostics USD 393M 27M 2026-03
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Terumo JPY 217.16B 12.86B 2025-09
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12